ENGOT-ov24-NSGO/AVANOVA
Study documentation (link to documents, only accessible with password to www.nsgo.org). Click HERE for access.
Study sponsor | NSGO |
NSGO Project Manager | Louisa Boufercha, NSGO, Rigshospitalet Copenhagen, Denmark. +45 3545 3398 |
Study chair | Mansoor Mirza, NSGO, Rigshospitalet Copenhagen, Denmark +45 3545 3939 |
Drug | Niraparib and Bevacizumab |
Phase | 2 |
Randomized trial | Yes |
Type | Open -label |
Total number of patients | 94 patients |
Number of patients recruited | Recruitment statistics – link |
Trial status | Recruiting |
Date of first site activated | 02.03.2016 |
eCRF | Open Clinica test- link (protected information – access only with login) Open Clinica Live – link (protected information – access only with login) |
Site list | Site list – link (protected information – access only with login) |
Protocol summary | ClinicalTrials.gov – link |